Admissions & Financial Aid
- Tuition & Fees
Local & Global Engagement
Office of Conflicts of Interest Administration
Welcome to Tufts University School of Medicine's Office of Conflicts of Interest Administration. Medicine today often requires the dynamic interaction between the clinician/scientist and the pharmaceutical and medical device industries. Tufts School of Medicine has adopted a policy intended to identify, clarify and avoid conflicts of interest between industry and Tufts School of Medicine's physicians, physicians-in-training and students while also educating future physicians about the potential effects of physician-industry relationships on patient care.
There is a body of research that suggests that adverse consequences may derive from certain types of close relationships between healthcare providers and industry representatives. Medical schools train future physicians at a particularly formative time in their careers and thus have special responsibilities to communicate and model professional values and expectations while imparting clinical knowledge and skills.
It is important that universities monitor the influence of industry over medical educational content, learning objectives and research methodology especially given the important and appropriate role that University - industry relationships serve in the development of new science and therapeutics. It is equally important for educational institutions, including Tufts School of Medicine, to communicate to students the reasons for avoiding inappropriate influence and to model appropriate ethical behavior including appropriate scientific relationships with Industry.
Faculty at Tufts School of Medicine are welcomed to engage in outside activities with industry, whether remunerative or not, and whether or not related to their fields of academic interest, expertise or specialization. They may not, however, engage in activities that conflict with their responsibilities to Tufts School of Medicine or violate Tufts' Policy on Industry Conflicts of Interest. A conflict of interest exists when a faculty member has one of more financial or other interests that subjects him or her to influence. A conflict may also exist if the magnitude of the obligation created by outside activity is such that it would appear to compromise the faculty member's commitment to the Medical School.
All Tufts School of Medicine faculty, administrators and students are subject to the Medical School's Policy on Industry Conflicts of Interest. In the event that a faculty member is uncertain about whether an outside activity is permitted under the policy, he or she may consult with the Division or Department Chair or Dean or with a member of the Tufts School of Medicine Conflict of Interest Office. A faculty member may also request that an inquiry be directed to the Tufts School of Medicine COI Advisory Committee. For further information please contact the COI Administrators or email firstname.lastname@example.org.
- Revised Policy on Industry Conflicts of Interest (October 2020)
- Tutorial on Industry Conflicts of Interest
- Office of Research Administration
- Frequently Asked Questions
- Symposia on Conflicts of Interest: (TUSK Log-in required)
- Industry-Sponsored Speaker Programs—End of the Line?
- U.S. Supreme Court: FDA Approval and Drug Safety
- Legal Liability of Generic vs Brand Drug Manufacturers for Inadequate Product Labels
JAMA | July 2018
- Roundup litigation discovery documents: implications for public health and journal ethics
Journal of Public Health Policy | June 2018
- Promotion of Drugs for Off-label Uses: The US Food and Drug Administration at a Crossroads
Health Care Policy and Law | February 2017
- Conflicts of interest among committee members in the National Academies' genetically engineered crop study
PLOS ONE | February 2017
- Conflict of Interest Policies and Industry Relationships of Guideline Development Group Members: A Cross-Sectional Study of Clinical Practice Guidelines for Depression
Accountability in Research | February 2017
- Sugar Industry Science and Heart Disease
Accountability in Research | January 2017
- "Get the Consent"— Nonfinancial Conflict of Interest in Academic Clinical Research
Journal of Clinical Oncology | January 2017
- Why Having a (Nonfinancial) Interest Is Not a Conflict of Interest
PLOS Biology | December 2016
- Bridging the Academia/Industry Chasm: Proposed Solutions
Journal of Clinical Pharmacology | 2016
- FDA Approval of Drugs and Devices: Preemption of State Laws for "Parallel" Tort Claims
Journal of Health Care Law & Policy | 2015
- Tripartite Conflicts of Interest and High Stakes Patent Extensions in the DSM-5
Psychotherapy and Psychosomatics | 2014
- From caveat emptor to caveat venditor: time to stop the influence of money on practice guideline development
Journal of Evaluation in Clinical Practice | 2014
- On Access and Accountability — Two Supreme Court Rulings on Generic Drugs
The New England Journal of Medicine | August 2013
- Pharmaceutical Speakers’ Bureaus, Academic Freedom, and the Management of Promotional Speaking at Academic Medical Centers
Journal of Law, Medicine & Ethics | 2012
- Revisiting the Physician/Industry Alliance: The Bayh-Dole Act and Conflict of Interest Management at Academic Medical Centers
Journal of Medicine and Law | 2010